Kim Seok-Hyung, Oh Donghwan, Jung Kwon Soo, Lee Jung Eun, Kim Hyunwook, Kim Hyung Jong, Kim Beom Seok, Park Hyeong Cheon, Lee Byoung Kwon, Choi Hoon Young
Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
PLoS One. 2017 Sep 28;12(9):e0185522. doi: 10.1371/journal.pone.0185522. eCollection 2017.
The apolipoprotein B/A-1 ratio has been reported to be one of the strongest risk predictors of cardiovascular events. However, its prognostic value for cardiovascular disease is still uncertain, especially in patients with chronic kidney disease. This study aimed to investigate whether the association between the apolipoprotein B/A-I ratio and coronary artery calcification differed according to kidney function in a healthy population.
Of the data from 7,780 participants from the medical records database in Gangnam Severance Hospital from 2005 through 2016, a cross-sectional analysis included participants with an estimated glomerular filtration rate (eGFR) ≥ 60 mL/min/1.73 m2 determined based on the Chronic Kidney Disease -Epidemiology Collaboration equation (n = 1,800). Mild renal insufficiency was defined as an eGFR of 60-90 mL/min/1.73 m2. Coronary artery calcification measured with computed tomography was defined as an above-zero score. Logistic regression analyses were used to determine the association between coronary calcification and the apolipoprotein B/A-I ratio according to eGFR by adjusting for the influence of confounders.
The mean apolipoprotein B/A-I level was significantly higher in the participants with coronary artery calcification than in the participants without coronary artery calcification. The apolipoprotein B/A-I ratio was significantly different according to coronary artery calcification in the participants with normal kidney function, but in the participants with mild renal insufficiency, it was not different. After adjusting for age, male sex, systolic blood pressure, body mass index, current smoking status, and fasting plasma glucose, the apolipoprotein B/A-I ratio was significantly associated with an increased risk of coronary artery calcification in participants with normal kidney function (odds ratio = 2.411, p = 0.011), while in the participants with mild renal insufficiency, the apolipoprotein B/A-I ratio was not associated with coronary artery calcification.
Our study showed that the predictive value of apolipoprotein B/A-I ratio for coronary artery calcification may differ according to kidney function.
载脂蛋白B/A-1比值据报道是心血管事件最强的风险预测指标之一。然而,其对心血管疾病的预后价值仍不确定,尤其是在慢性肾脏病患者中。本研究旨在调查在健康人群中,载脂蛋白B/A-I比值与冠状动脉钙化之间的关联是否因肾功能不同而存在差异。
对2005年至2016年江南Severance医院病历数据库中7780名参与者的数据进行横断面分析,纳入根据慢性肾脏病流行病学协作组方程估算肾小球滤过率(eGFR)≥60 mL/min/1.73 m²的参与者(n = 1800)。轻度肾功能不全定义为eGFR为60 - 90 mL/min/1.73 m²。通过计算机断层扫描测量的冠状动脉钙化定义为评分高于零。采用逻辑回归分析,通过调整混杂因素的影响,确定根据eGFR,冠状动脉钙化与载脂蛋白B/A-I比值之间的关联。
有冠状动脉钙化的参与者的平均载脂蛋白B/A-I水平显著高于无冠状动脉钙化的参与者。在肾功能正常的参与者中,载脂蛋白B/A-I比值根据冠状动脉钙化情况有显著差异,但在轻度肾功能不全的参与者中则无差异。在调整年龄、男性性别、收缩压、体重指数、当前吸烟状况和空腹血糖后,载脂蛋白B/A-I比值与肾功能正常的参与者冠状动脉钙化风险增加显著相关(比值比 = 2.411,p = 0.011),而在轻度肾功能不全的参与者中,载脂蛋白B/A-I比值与冠状动脉钙化无关。
我们的研究表明,载脂蛋白B/A-I比值对冠状动脉钙化的预测价值可能因肾功能不同而存在差异。